Malaria Elimination and Eradication: A Look Back at Our 2012 O’Neill Institute Colloquium
O’Neill Institute | Leave a Comment
In the spirit of looking back and reviewing the work of the O’Neill Institute, we would like to share two presentations with you from our most recent O’Neill Institute Colloquium, David Bowen, “Malaria Elimination: Politics and Practicalities” and Joel Breman, “Eradicating Malaria: The Holy Grail of Tropical Medicine.”
David Bowen came to Malaria No More from the the Bill and Melinda Gates Foundation,
where he served as deputy director for global health policy and advocacy. In this role, he was responsible for interactions between the foundation and governments worldwide on global health. Dr. Bowen was formerly chief health counsel to Senator Edward Kennedy and staff director for health of the Senate Committee on Health, Education, Labor and Pensions. He left the Senate staff following the successful enactment of health care reform legislation. In 1999, Dr. Bowen joined the staff of the Senate Committee on Health, Education, Labor and Pensions as a Congressional Fellow with the American Association for the Advancement of Science. From 2000 to 2002, he held a joint appointment as a visiting fellow in the Department of Health Care Policy at the Harvard Medical School. Prior to joining the committee staff, Dr. Bowen received his undergraduate education at Brown University then earned a PhD in neurobiology at the University of California, San Francisco.
Joel G. Breman, M.D., D.T.P.H., is Senior Scientist Emeritus at the Fogarty International Center, U.S. National Institutes of Health. For the past 45 years he has worked to eradicate and control some of the most dangerous microbes on earth, first with the Centers for Disease Control and Prevention, the World Health Organization, and for the past 17 years with NIH. He was educated at the University of California, Los Angeles (UCLA); Keck School of Medicine, University of Southern California (USC); and the London School of Hygiene and Tropical Medicine. He was trained in internal medicine, infectious diseases, tropical medicine, and in epidemiology. Dr. Breman was Chief Advisor to the Guinean Smallpox Eradication-Measles Control Program from 1967-1969. From 1972-1976, he was responsible for disease surveillance and vaccine research with the Organization for Coordination and Cooperation in the Control of the Major Endemic Diseases in Burkina Faso where he was Chief of the Epidemiology Section. In 1976, in the Democratic Republic of the Congo (DRC, ex-Zaire), Dr. Breman investigated the first outbreak of Ebola Hemorrhagic Fever for which he received the Order of the Leopard National Award, the highest award given by the government of the DRC. He was Deputy Chief of the Smallpox Eradication Unit, WHO, from 1977-1980 responsible for coordinating orthopoxvirus research and global certification of smallpox eradication. In 1980, Dr. Breman returned to the CDC and began work on malaria. He was Chief of the Malaria Control Activity and Deputy Branch Chief, responsible for research, control and training in 13 African countries as part of a child-survival program. Dr. Breman joined the Fogarty International Center, National Institutes of Health in 1995. He has been Deputy Director of the Division of International Training and Research, director of several infectious diseases and research and training programs before retiring in 2010.
The O’Neill Institute Colloquium, offered annually, is an interdisciplinary course that draws from the work of scholars, policymakers, and the general health community. The course is taught and moderated by Institute-affiliated faculty, and the goal of the Colloquium is to engage leading thinkers and students in an enriching dialogue regarding critical health law issues. National and international scholars, practitioners and policymakers explore contemporary health issues with top students interested in health law and related issues from schools throughout the University. The Colloquium sessions are open to University faculty members and interested members of the public.